Literature DB >> 21548792

Aspirin-triggered lipoxin A4 (15-epi-LXA4) increases the endothelial viability of human corneas storage in Optisol-GS.

Jiucheng He1, Azucena H Kakazu, Nicolas G Bazan, Haydee E P Bazan.   

Abstract

PURPOSE: The human corneal endothelium has a very low mitotic rate, and with aging there is a decrease in the number of cells. 15-epi-LXA4 is an anti-inflammatory, bioactive lipid formed when aspirin acetylates cyclooxygenease-2 and redirects cyclooxygenease-2 catalytic activity away from prostaglandins. The purpose of the current study was to evaluate the action of 15-epi-LXA4 in the endothelium viability of human corneas stored in Optisol-GS.
METHODS: Human corneal endothelial (HCE) cells along with the Descemet's membrane were isolated from fresh human eyes obtained from National Disease Research Interchange. Cell phenotype was identified by using the tight junctions cell marker ZO-1. LXA4 receptor (FPR2/ALX) was detected by immunostaining of HCE cells and human corneal tissue using a polyclonal antibody. Cell proliferation was evaluated with Ki-67 antibody. To measure cell migration, confluent HCE cells were wounded by a linear scraping with a sterile pipette tip in the center of the well and incubated for 24 h with or without 15-epi-LXA4. To evaluate the reparative capacity of 15-epi-LXA4, 7 pairs of human corneas were incubated in Dulbecco's modified Eagle's medium/F12 media at 37°C with or without 100 nM 15-epi-LXA4 for 24 h and then stored at 4°C in Optisol-GS for 12 days. Endothelial viability was assessed by 2 staining techniques: a viability/cytotoxicity kit and trypan blue combined with alizarin red S.
RESULTS: HCE cells and the endothelium of human corneal sections strongly expressed the LXA4 receptor. There was a 3-fold increase in cell proliferation when HCE cells were incubated with 100 nM 15-epi-LXA4 for 24 h. No significant migration was observed after 24 h incubation with 15-epi-LXA4. Corneas incubated for 24 h in Dulbecco's modified Eagle's medium/F12 media in the presence of 15-epi-LXA4 and then stored for 12 days in Optisol-GS had a 36% to 56% increase in viability compared with controls without 15-epi-LXA4.
CONCLUSIONS: 15-epi-LXA4 is an important mediator that protects the integrity of the human endothelium during corneal preservation in Optisol-GS.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21548792      PMCID: PMC3107975          DOI: 10.1089/jop.2010.0187

Source DB:  PubMed          Journal:  J Ocul Pharmacol Ther        ISSN: 1080-7683            Impact factor:   2.671


  34 in total

Review 1.  Novel lipid mediators and resolution mechanisms in acute inflammation: to resolve or not?

Authors:  Charles N Serhan
Journal:  Am J Pathol       Date:  2010-09-02       Impact factor: 4.307

2.  Evaluation of the deswelling period in dextran-containing medium after corneal organ culture.

Authors:  V M Borderie; M Baudrimont; M Lopez; S Carvajal; L Laroche
Journal:  Cornea       Date:  1997-03       Impact factor: 2.651

Review 3.  Cellular changes in transplanted human corneas.

Authors:  W M Bourne
Journal:  Cornea       Date:  2001-08       Impact factor: 2.651

4.  Factors influencing the suitability of organ-cultured corneas for transplantation.

Authors:  W J Armitage; D L Easty
Journal:  Invest Ophthalmol Vis Sci       Date:  1997-01       Impact factor: 4.799

5.  EDTA: a promoter of proliferation in human corneal endothelium.

Authors:  T Senoo; Y Obara; N C Joyce
Journal:  Invest Ophthalmol Vis Sci       Date:  2000-09       Impact factor: 4.799

Review 6.  Lipoxins and novel aspirin-triggered 15-epi-lipoxins (ATL): a jungle of cell-cell interactions or a therapeutic opportunity?

Authors:  C N Serhan
Journal:  Prostaglandins       Date:  1997-02

7.  Central corneal endothelial cell changes over a ten-year period.

Authors:  W M Bourne; L R Nelson; D O Hodge
Journal:  Invest Ophthalmol Vis Sci       Date:  1997-03       Impact factor: 4.799

8.  Primary corneal graft failure. A national reporting system. Medical Advisory Board of the Eye Bank Association of America.

Authors:  K R Wilhelmus; R D Stulting; J Sugar; M M Khan
Journal:  Arch Ophthalmol       Date:  1995-12

9.  Aspirin-triggered 15-epi-lipoxin A4 (LXA4) and LXA4 stable analogues are potent inhibitors of acute inflammation: evidence for anti-inflammatory receptors.

Authors:  T Takano; S Fiore; J F Maddox; H R Brady; N A Petasis; C N Serhan
Journal:  J Exp Med       Date:  1997-05-05       Impact factor: 14.307

10.  Identification of a human enterocyte lipoxin A4 receptor that is regulated by interleukin (IL)-13 and interferon gamma and inhibits tumor necrosis factor alpha-induced IL-8 release.

Authors:  K Gronert; A Gewirtz; J L Madara; C N Serhan
Journal:  J Exp Med       Date:  1998-04-20       Impact factor: 14.307

View more
  7 in total

1.  Lipoxin A₄ inhibits platelet-activating factor inflammatory response and stimulates corneal wound healing of injuries that compromise the stroma.

Authors:  Azucena Kakazu; Jiucheng He; Sachidananda Kenchegowda; Haydee E P Bazan
Journal:  Exp Eye Res       Date:  2012-07-22       Impact factor: 3.467

2.  Identification and Profiling of Specialized Pro-Resolving Mediators in Human Tears by Lipid Mediator Metabolomics.

Authors:  Justin T English; Paul C Norris; Robin R Hodges; Darlene A Dartt; Charles N Serhan
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2017-01-19       Impact factor: 4.006

Review 3.  Immune regulation of the ocular surface.

Authors:  Yihe Chen; Shudan Wang; Hamid Alemi; Thomas Dohlman; Reza Dana
Journal:  Exp Eye Res       Date:  2022-03-04       Impact factor: 3.770

Review 4.  The potential of lipid mediator networks as ocular surface therapeutics and biomarkers.

Authors:  Becca A Flitter; Xiaohui Fang; Michael A Matthay; Karsten Gronert
Journal:  Ocul Surf       Date:  2020-04-29       Impact factor: 5.033

5.  The Association of Free Fatty Acids and Eicosanoids with the Severity of Depressive Symptoms in Stroke Patients.

Authors:  Dariusz Kotlega; Agnieszka Zembron-Lacny; Monika Golab-Janowska; Przemyslaw Nowacki; Malgorzata Szczuko
Journal:  Int J Mol Sci       Date:  2020-07-23       Impact factor: 5.923

6.  Resolvin D1 reduces the immunoinflammatory response of the rat eye following uveitis.

Authors:  Rossi Settimio; Di Filippo Clara; Ferraraccio Franca; Simonelli Francesca; D'Amico Michele
Journal:  Mediators Inflamm       Date:  2012-12-10       Impact factor: 4.711

Review 7.  Formyl peptide receptors in the mucosal immune system.

Authors:  Yu Sun Jeong; Yoe-Sik Bae
Journal:  Exp Mol Med       Date:  2020-10-20       Impact factor: 8.718

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.